logo
Share SHARE
FONT-SIZE Plus   Neg

Oculus Gets $5.1 Mln Licensing Fee From More Pharma

Oculus Innovative Sciences, Inc. (OCLS),a California-based nutrition and drug company, Thursday said it received a $5.1 million payment in view of a licensing agreement it executed on August 9, 2012, with More Pharma.

More Pharma had agreed earlier to pay an upfront $5.1 million fee for the exclusive licensing of Oculus' Microcyn-based human healthcare products in Mexico, South/Central America and the Caribbean.

Further, More Pharma will underwrite all costs for regulatory reviews and approval efforts needed for the transition of the marketing and sales effort in the aforementioned countries, said Oculus.

Wednesday, Oculus closed at $0.94 on the Nasdaq.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
British integrated oil and gas major BP Plc. (BP.L, BP_UN.TO, BP) Tuesday announced a narrower replacement cost loss for the second quarter from the prior year. Revenues were hit by lower oil prices. The company said the results draws a line under Deepwater Horizon liabilities, despite strong operations... Telecommunications giant Verizon Communications, Inc. on Tuesday an 83 percent plunge in profit for the second quarter from last year on lower revenues and higher expenses. However, adjusted earnings per share for the quarter topped analysts' expectations, while revenues missed their estimates. Telecommunications giant Verizon Communications, Inc. on Tuesday an 83 percent plunge in profit for the second quarter from last year on lower revenues and higher expenses. However, adjusted earnings per share for the quarter topped analysts' expectations, while revenues missed their estimates.
comments powered by Disqus
Follow RTT